Literature DB >> 3021480

Genetic marker patterns and endogenous mammary tumor virus genes in inbred mouse strains of Japan.

S Imai, J Morimoto, Y Tsubura, K Esaki, R Michalides, R S Holmes, O von Deimling, J Hilgers.   

Abstract

In order to establish the genetic relatedness of the inbred mouse strains kept in Nara, genetic marker patterns were determined in conjunction with a study on endogenous mammary tumor viral genes in these strains. Isoenzyme patterns combined with patterns of other genetic markers, show that the unrelatedness between various inbred strains of the dd stock is as high or even higher as between strains of known different origin and geneology. Based on endogenous viral gene patterns the dd stock derived mice can be subdivided into three group, DDD, DDN, DDO, KF and DD/Tbr. The DD/Tbr and its foster-nursed substrain (DD/Tbrf) have the lowest number of endogenous viral genes, i.e. two, while the other strains carry 4-6 such genes. The SLN and SHN strains, derived from a Swiss stock, have a similar pattern of viral genes different that of all other strains studied, also strains of Swiss origin from other sources, such as the NFS and the GR.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021480     DOI: 10.1538/expanim1978.35.3_263

Source DB:  PubMed          Journal:  Jikken Dobutsu        ISSN: 0007-5124


  3 in total

1.  Mouse Mammary Tumor Virus Proviral Integration in the DD/Tbr Mice.

Authors: 
Journal:  Breast Cancer       Date:  1994-07-30       Impact factor: 4.239

2.  Esterase-18 (ES-18) of the house mouse (Mus musculus): biochemical characterization and genetics of an allozyme system linked to chromosome 19.

Authors:  O H von Deimling; A Gaa; M M Simon
Journal:  Biochem Genet       Date:  1988-10       Impact factor: 1.890

3.  Esterase-25 (Es-25): identification and characterization of a new kidney arylesterase of the house mouse, genetically linked to Ly-18 on chromosome 12.

Authors:  O H von Deimling; B A Taylor
Journal:  Biochem Genet       Date:  1987-10       Impact factor: 1.890

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.